This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Why Organovo Holdings (ONVO) Is Soaring Today

NEW YORK (TheStreet) -- Shares of Organovo Holdings (ONVO - Get Report) on Wednesday rose 10.2% to $9.60,  after the functional human tissue designer announced that it had reached a milestone ahead of schedule.

Organovo revealed that it had made its first delivery of 3D liver tissue to a key opinion leader outside the company. Organovo had originally scheduled this delivery for April but accomplished it more than two months ahead of schedule. As a result, the company has moved up its previously scheduled commercial release of the 3D liver tissue product from December to an unspecified earlier date.

"This is an important milestone for Organovo R&D," said Dr. Sharon Presnell, Chief Technology Officer and Executive Vice President of Research and Development, in the company's statement. "In developing these tissues, we have gone through a careful set of research studies involving many individual tissues, and greatly increased our ability to produce them.  By the end of January, we expect to have bioprinted nearly four hundred 3D Liver tissues during the month."

The stock hit a high of $10.47 and a low of $9.57 for the day and had a volume of 12,083,151, nearly double its average of 6,042,810. It has a one-year high of $13.65 and a one-year low of $3.27.

Must Read: Vale S.A. (VALE) Still a "Hold," Says TheStreet

ONVO Chart

ONVO data by YCharts

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
ONVO $2.09 0.00%
AAPL $94.02 0.00%
FB $104.07 0.00%
GOOG $683.57 0.00%
TSLA $162.60 0.00%


Chart of I:DJI
DOW 16,204.97 -211.61 -1.29%
S&P 500 1,880.05 -35.40 -1.85%
NASDAQ 4,363.1440 -146.4150 -3.25%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs